Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.3 EUR | +1.65% | +13.03% | +71.11% |
Apr. 17 | Medincell: share price rises following agreement with AbbVie | CF |
Apr. 16 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+71.11% | 372M | |
+25.61% | 660B | |
+23.15% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+13.06% | 219B | |
-9.28% | 196B | |
+7.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- MEDCL Stock
- News MedinCell S.A.
- Medincell S.A. Reports Earnings Results for the Full Year Ended March 31, 2020